Phreesia, Inc. (NYSE:PHR) SVP Sells $15,659.10 in Stock

Phreesia, Inc. (NYSE:PHR) SVP Amy Beth Vanduyn sold 685 shares of the business’s stock in a transaction dated Monday, April 15th. The stock was sold at an average price of $22.86, for a total value of $15,659.10. Following the transaction, the senior vice president now directly owns 119,010 shares of the company’s stock, valued at $2,720,568.60. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.

Amy Beth Vanduyn also recently made the following trade(s):

• On Monday, April 8th, Amy Beth Vanduyn sold 3,354 shares of Phreesia stock. The stock was sold at an average price of $22.62, for a total value of $75,867.48.

Phreesia Price Performance

PHR stock traded up $0.16 on Wednesday, reaching $23.16. 383,738 shares of the company’s stock were exchanged, compared to its average volume of 522,719. The stock has a fifty day moving average of $24.56 and a 200-day moving average of $21.23. Phreesia, Inc. has a twelve month low of $12.05 and a twelve month high of $34.98. The firm has a market cap of $1.31 billion, a PE ratio of -9.19 and a beta of 0.92. The company has a quick ratio of 1.78, a current ratio of 1.78 and a debt-to-equity ratio of 0.02.

Phreesia (NYSE:PHR) last posted its earnings results on Thursday, March 14th. The company reported ($0.56) earnings per share for the quarter, beating the consensus estimate of ($0.58) by $0.02. The company had revenue of $95.00 million for the quarter, compared to analyst estimates of $93.52 million. Phreesia had a negative return on equity of 53.33% and a negative net margin of 38.42%. Phreesia’s revenue was up 24.0% compared to the same quarter last year. During the same quarter in the prior year, the company earned ($0.72) earnings per share. As a group, equities analysts predict that Phreesia, Inc. will post -1.48 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of equities research analysts have weighed in on the company. DA Davidson reiterated a “neutral” rating and issued a $32.00 price objective on shares of Phreesia in a research note on Friday, March 15th. Royal Bank of Canada reiterated a “sector perform” rating and issued a $23.00 price objective on shares of Phreesia in a research note on Thursday, March 21st. Needham & Company LLC reiterated a “buy” rating and issued a $29.00 price objective on shares of Phreesia in a research note on Friday, March 15th. Canaccord Genuity Group boosted their price objective on Phreesia from $36.00 to $37.00 and gave the company a “buy” rating in a research note on Friday, March 15th. Finally, Barclays initiated coverage on Phreesia in a research note on Wednesday, January 3rd. They issued an “overweight” rating and a $29.00 price objective for the company. Two investment analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $31.62.

Institutional Trading of Phreesia

Several institutional investors and hedge funds have recently made changes to their positions in PHR. Envestnet Asset Management Inc. lifted its position in shares of Phreesia by 11.7% in the first quarter. Envestnet Asset Management Inc. now owns 9,692 shares of the company’s stock valued at $255,000 after acquiring an additional 1,015 shares in the last quarter. JPMorgan Chase & Co. lifted its position in Phreesia by 160.9% during the first quarter. JPMorgan Chase & Co. now owns 85,546 shares of the company’s stock worth $2,254,000 after buying an additional 52,755 shares during the period. Raymond James Financial Services Advisors Inc. lifted its position in Phreesia by 20.7% during the first quarter. Raymond James Financial Services Advisors Inc. now owns 8,427 shares of the company’s stock worth $222,000 after buying an additional 1,447 shares during the period. Bank of New York Mellon Corp lifted its position in Phreesia by 0.9% during the first quarter. Bank of New York Mellon Corp now owns 219,598 shares of the company’s stock worth $5,788,000 after buying an additional 2,047 shares during the period. Finally, PNC Financial Services Group Inc. lifted its position in Phreesia by 27.6% during the first quarter. PNC Financial Services Group Inc. now owns 16,059 shares of the company’s stock worth $424,000 after buying an additional 3,473 shares during the period. 92.10% of the stock is currently owned by hedge funds and other institutional investors.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.